Back to Search Start Over

Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project

Authors :
Morton, Lindsay M.
Slager, Susan L.
Cerhan, James R.
Wang, Sophia S.
Vajdic, Claire M.
Skibola, Christine F.
Bracci, Paige M.
de Sanjosé, Silvia
Smedby, Karin E.
Chiu, Brian C. H.
Zhang, Yawei
Mbulaiteye, Sam M.
Monnereau, Alain
Turner, Jennifer J.
Clavel, Jacqueline
Adami, Hans-Olov
Chang, Ellen T.
Glimelius, Bengt
Hjalgrim, Henrik
Melbye, Mads
Crosignani, Paolo
di Lollo, Simonetta
Miligi, Lucia
Nanni, Oriana
Ramazzotti, Valerio
Rodella, Stefania
Costantini, Adele Seniori
Stagnaro, Emanuele
Tumino, Rosario
Vindigni, Carla
Vineis, Paolo
Becker, Nikolaus
Benavente, Yolanda
Boffetta, Paolo
Brennan, Paul
Cocco, Pierluigi
Foretova, Lenka
Maynadié, Marc
Nieters, Alexandra
Staines, Anthony
Colt, Joanne S.
Cozen, Wendy
Davis, Scott
de Roos, Anneclaire J.
Hartge, Patricia
Rothman, Nathaniel
Severson, Richard K.
Holly, Elizabeth A.
Call, Timothy G.
Feldman, Andrew L.
Habermann, Thomas M.
Liebow, Mark
Blair, Aaron
Cantor, Kenneth P.
Kane, Eleanor V.
Lightfoot, Tracy
Roman, Eve
Smith, Alex
Brooks-Wilson, Angela
Connors, Joseph M.
Gascoyne, Randy D.
Spinelli, John J.
Armstrong, Bruce K.
Kricker, Anne
Holford, Theodore R.
Lan, Qing
Zheng, Tongzhang
Orsi, Laurent
Dal Maso, Luigino
Franceschi, Silvia
La Vecchia, Carlo
Negri, Eva
Serraino, Diego
Bernstein, Leslie
Levine, Alexandra
Friedberg, Jonathan W.
Kelly, Jennifer L.
Berndt, Sonja I.
Birmann, Brenda M.
Clarke, Christina A.
Flowers, Christopher R.
Foran, James M.
Kadin, Marshall E.
Paltiel, Ora
Weisenburger, Dennis D.
Linet, Martha S.
Sampson, Joshua N.
Source :
Journal of the National Cancer Institute. Monographs; August 2014, Vol. 2014 Issue: 48 p130-130, 1p
Publication Year :
2014

Abstract

<sec><st>Background</st> Non-Hodgkin lymphoma (NHL) comprises biologically and clinically heterogeneous subtypes. Previously, study size has limited the ability to compare and contrast the risk factor profiles among these heterogeneous subtypes. </sec> <sec><st>Methods</st> We pooled individual-level data from 17 471 NHL cases and 23 096 controls in 20 case–control studies from the International Lymphoma Epidemiology Consortium (InterLymph). We estimated the associations, measured as odds ratios, between each of 11 NHL subtypes and self-reported medical history, family history of hematologic malignancy, lifestyle factors, and occupation. We then assessed the heterogeneity of associations by evaluating the variability (Q</it> value) of the estimated odds ratios for a given exposure among subtypes. Finally, we organized the subtypes into a hierarchical tree to identify groups that had similar risk factor profiles. Statistical significance of tree partitions was estimated by permutation-based P</it> values (P</it> <inf>NODE</inf>). </sec> <sec><st>Results</st> Risks differed statistically significantly among NHL subtypes for medical history factors (autoimmune diseases, hepatitis C virus seropositivity, eczema, and blood transfusion), family history of leukemia and multiple myeloma, alcohol consumption, cigarette smoking, and certain occupations, whereas generally homogeneous risks among subtypes were observed for family history of NHL, recreational sun exposure, hay fever, allergy, and socioeconomic status. Overall, the greatest difference in risk factors occurred between T-cell and B-cell lymphomas (P</it> <inf>NODE</inf> < 1.0×10−4), with increased risks generally restricted to T-cell lymphomas for eczema, T-cell-activating autoimmune diseases, family history of multiple myeloma, and occupation as a painter. We further observed substantial heterogeneity among B-cell lymphomas (P</it> <inf>NODE</inf> < 1.0×10−4). Increased risks for B-cell-activating autoimmune disease and hepatitis C virus seropositivity and decreased risks for alcohol consumption and occupation as a teacher generally were restricted to marginal zone lymphoma, Burkitt/Burkitt-like lymphoma/leukemia, diffuse large B-cell lymphoma, and/or lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. </sec> <sec><st>Conclusions</st> Using a novel approach to investigate etiologic heterogeneity among NHL subtypes, we identified risk factors that were common among subtypes as well as risk factors that appeared to be distinct among individual or a few subtypes, suggesting both subtype-specific and shared underlying mechanisms. Further research is needed to test putative mechanisms, investigate other risk factors (eg, other infections, environmental exposures, and diet), and evaluate potential joint effects with genetic susceptibility. </sec>

Details

Language :
English
ISSN :
10526773 and 17456614
Volume :
2014
Issue :
48
Database :
Supplemental Index
Journal :
Journal of the National Cancer Institute. Monographs
Publication Type :
Periodical
Accession number :
ejs33657642
Full Text :
https://doi.org/10.1093/jncimonographs/lgu013